Your browser doesn't support javascript.
loading
BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement.
Wang, Yiyun; Zu, Cheng; Teng, Xinyi; Yang, Li; Zhang, Mingming; Hong, Ruimin; Zhao, Houli; Cui, Jiazhen; Xu, Huijun; Hongsheng, Alex Chang; Hu, Yongxian; Huang, He.
Afiliação
  • Wang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine.
  • Zu C; Institute of Hematology, Zhejiang University.
  • Teng X; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy.
  • Yang L; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, Zhejiang Province, China.
  • Zhang M; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine.
  • Hong R; Institute of Hematology, Zhejiang University.
  • Zhao H; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy.
  • Cui J; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, Zhejiang Province, China.
  • Xu H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine.
  • Hongsheng AC; Institute of Hematology, Zhejiang University.
  • Hu Y; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy.
  • Huang H; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, Zhejiang Province, China.
J Immunother ; 45(1): 25-34, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34874329
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article